Physician profile
Thad A Labbe
NPI 1346284866
$2,759.78
in general payments reported to CMS, 2019-2025
16 companies · $569 in 2025
The $569 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $88.34 · 2021: $247 · 2022: $479 · 2023: $576 · 2024: $504 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $976.67 | 2022-2025 | |
| Alcon Vision LLC | $487.56 | 2019-2025 | Rocklatan, Clareon, Unity |
| Bausch & Lomb Americas INC. | $405.75 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Allergan, INC. | $257.19 | 2019-2022 | |
| Ocular Therapeutix, INC. | $156.29 | 2023-2024 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.70 | 2019-2021 | |
| Shire North American Group INC | $133.90 | 2019 | |
| Aerie Pharmaceuticals, INC. | $39.02 | 2019-2020 | |
| Sight Sciences, INC. | $33.70 | 2024 | Omni Surgical System |
| Horizon Therapeutics Plc | $28.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.84 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.89 | 2020 | |
| Apellis Pharmaceuticals, INC. | $19.94 | 2025 | Syfovre |
| Kala Pharmaceuticals, INC. | $13.25 | 2022 | |
| Thea Pharma INC. | $13.18 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $10.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thad Labbe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.